Company: BIAF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001840
Chunk: 1050

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9C
Chunk 1050
---
,098  
     3,972,745 

    Non-current assets: 

    Property and equipment,
    net 
     375,385  
     458,633 
  
    Operating lease right-of-use
    asset, net 
     463,011  
     370,312 
  
    Finance lease right-of-use
    asset, net 
     780,872  
     1,165,844 
  
    Goodwill 
     1,404,486  
     1,404,486 
  
    Intangible assets, net 
     775,139  
     833,472 
  
    Other
    assets 
     19,676  
     16,060 

    Total assets 
    $6,513,667  
    $8,221,552 

    LIABILITIES AND STOCKHOLDERS’
    EQUITY 

    Current liabilities: 

    Accounts payable 
    $987,311  
    $604,789 
  
    Accrued expenses 
     1,398,722  
     1,149,811 
  
    Unearned revenue 
     24,404  
     33,058 
  
    Operating lease liability,
    current portion 
     127,498  
     94,708 
  
    Finance lease liability,
    current portion 
     395,301  
     365,463 
  
    Notes
    payable, current portion 
     171,669  
     — 

    Total current liabilities 
     3,104,905  
     2,247,829 

    Non-current liabilities 

    Operating lease liability,
    net of current portion 
     342,098  
     283,001 
  
    Finance lease liability,
    net of current portion 
     444,448  
     835,467 
  
    Notes payable, net of current portion 
     20,180  
     — 

    Total liabilities 
     3,911,631  
     3,366,297 

    Commitments and contingencies (See Note
    11) 
     -   
     -  

    Stockholders’ equity: 

    Preferred stock, no
    shares issued or outstanding at December 31, 2024 and 2023, respectively